Details of the Drug
General Information of Drug (ID: DMTN1P2)
Drug Name |
CSL-324
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Anti-GCSF human mAb (inflammation), CSL; Anti-GCSF human monoclonal antibody (inflammation), CSL; Soluble human GCSFR extracellular domain-Fc (inflammation), CSL; Soluble human GCSFR extracellular domain-Fc (arthritis), MuriGen/CSL LTd; Soluble human granulocyte-colony stimulating factor receptor extracellular domain-Fc (arthritis), MuriGen/CSL LTd; Soluble human granulocyte-colony stimulating factor receptor extracellular domain-Fc (arthritis), MuriGen/Zenyth
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Antibody
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Inflammation | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | 1A00-CA43.1 | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||